Vaccine-associated feline sarcoma: current perspectives.

Area of Science:

• Veterinary Oncology
• Immunology

Background:

• Feline injection site sarcomas (FISS), also known as vaccine-associated sarcomas, are iatrogenic tumors recognized for over two decades.
• Vaccination against rabies and feline leukemia virus are common inciting causes, though the exact etiopathogenesis remains unclear.
• Chronic inflammation induced by vaccines or other injections is widely believed to play a critical role in FISS development.

Purpose of the Study:

• To review the current understanding of feline injection site sarcomas (FISS).
• To highlight the role of inflammation in FISS development.
• To emphasize the importance of vaccination guidelines and early detection in managing FISS.

Main Methods:

• Literature review of feline injection site sarcomas (FISS).
• Analysis of the proposed etiopathogenesis involving inflammation.
• Discussion of current therapeutic strategies and their limitations.

Main Results:

• FISS are locally invasive tumors with a high rate of recurrence, even with aggressive multimodal therapy.
• Multimodal treatment involving surgery, radiation therapy, and potentially chemotherapy or immunotherapy is recommended.
• Despite treatment, many cats with FISS have a poor prognosis.

Conclusions:

• Veterinarians must adhere to established vaccination guidelines to minimize FISS risk in cats.
• Early detection and client education are crucial for successful FISS treatment.
• Ongoing research into FISS pathogenesis and improved therapeutic strategies is warranted.